LASR vs. TERN

Last updated Apr 1, 2026

Compare and contrast key facts about nLIGHT, Inc. (LASR) and Terns Pharmaceuticals, Inc. (TERN).

Performance

LASR vs. TERN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in nLIGHT, Inc. (LASR) and Terns Pharmaceuticals, Inc. (TERN). The values are adjusted to include any dividend payments, if applicable.

LASR vs. TERN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
LASR nLIGHT, Inc.	52.01%	257.58%	-22.30%	33.14%	-57.66%	-29.16%
TERN Terns Pharmaceuticals, Inc.	30.50%	629.24%	-14.64%	-36.25%	43.99%	-61.56%

Fundamentals

EPS LASR : -$0.47 TERN : -$1.03
Total Revenue (TTM) LASR : $261.33M TERN : $0.00
Gross Profit (TTM) LASR : $77.96M TERN : -$108.00K
EBITDA (TTM) LASR : -$28.35M TERN : -$101.49M

Returns By Period

In the year-to-date period, LASR achieves a 52.01% return, which is significantly higher than TERN's 30.50% return.

LASR

• 1D: 5.59%
• 1M: 1.48%
• YTD: 52.01%
• 6M: 92.44%
• 1Y: 633.85%
• 3Y*: 77.59%
• 5Y*: 11.42%
• 10Y*: —

TERN

• 1D: -0.30%
• 1M: 25.17%
• YTD: 30.50%
• 6M: 602.00%
• 1Y: 1,810.14%
• 3Y*: 64.52%
• 5Y*: 20.66%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

LASR vs. TERN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LASR

LASR Risk / Return Rank: 99
LASR Sharpe Ratio Rank: 100
LASR Sortino Ratio Rank: 99
LASR Omega Ratio Rank: 98
LASR Calmar Ratio Rank: 100
LASR Martin Ratio Rank: 100

TERN

TERN Risk / Return Rank: 100
TERN Sharpe Ratio Rank: 100
TERN Sortino Ratio Rank: 100
TERN Omega Ratio Rank: 99
TERN Calmar Ratio Rank: 100
TERN Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LASR vs. TERN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for nLIGHT, Inc. (LASR) and Terns Pharmaceuticals, Inc. (TERN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LASR	TERN	Difference
Sharpe ratio Return per unit of total volatility	7.60	17.29	-9.69
Sortino ratio Return per unit of downside risk	5.18	8.80	-3.63
Omega ratio Gain probability vs. loss probability	1.69	2.08	-0.39
Calmar ratio Return relative to maximum drawdown	24.95	61.87	-36.92
Martin ratio Return relative to average drawdown	97.67	153.05	-55.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LASR vs. TERN - Sharpe Ratio Comparison

The current LASR Sharpe Ratio is 7.60, which is lower than the TERN Sharpe Ratio of 17.29. The chart below compares the historical Sharpe Ratios of LASR and TERN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	LASR	TERN	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	7.60	17.29	-9.69
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.18	0.22	-0.04
Sharpe Ratio (All Time) Calculated using the full available price history	0.15	0.23	-0.08

Correlation

The correlation between LASR and TERN is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

LASR vs. TERN - Dividend Comparison

Neither LASR nor TERN has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

LASR vs. TERN - Drawdown Comparison

The maximum LASR drawdown since its inception was -85.66%, smaller than the maximum TERN drawdown of -94.50%. Use the drawdown chart below to compare losses from any high point for LASR and TERN.

Drawdown Indicators

	LASR	TERN	Difference
Max Drawdown Largest peak-to-trough decline	-85.66%	-94.50%	+8.84%
Max Drawdown (1Y) Largest decline over 1 year	-24.74%	-27.56%	+2.82%
Max Drawdown (5Y) Largest decline over 5 years	-82.47%	-93.18%	+10.71%
Current Drawdown Current decline from peak	-20.53%	-0.85%	-19.68%
Average Drawdown Average peak-to-trough decline	-53.77%	-67.45%	+13.68%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.32%	11.14%	-4.82%

Volatility

LASR vs. TERN - Volatility Comparison

nLIGHT, Inc. (LASR) has a higher volatility of 31.42% compared to Terns Pharmaceuticals, Inc. (TERN) at 11.57%. This indicates that LASR's price experiences larger fluctuations and is considered to be riskier than TERN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LASR	TERN	Difference
Volatility (1M) Calculated over the trailing 1-month period	31.42%	11.57%	+19.85%
Volatility (6M) Calculated over the trailing 6-month period	57.76%	75.90%	-18.14%
Volatility (1Y) Calculated over the trailing 1-year period	84.25%	106.22%	-21.97%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	63.83%	95.73%	-31.90%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	65.87%	97.22%	-31.35%

Financials